Cargando…

Metallothionein 1M suppresses tumorigenesis in hepatocellular carcinoma

Members of the metallothionein (MT) family are involved in metal detoxifcation and in the protection of cells against certain electrophilic carcinogens. In present study, it was found that MT1M was downregulated in more than 77.1% (91/118) of hepatocellular carcinoma (HCC) tissues compared with adja...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Cheng-Lin, Pan, Bing, Pan, Ju-Hua, Gan, Mei-Fu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464848/ https://www.ncbi.nlm.nih.gov/pubmed/28380433 http://dx.doi.org/10.18632/oncotarget.16521

Ejemplares similares

DUSP12 regulates the tumorigenesis and prognosis of hepatocellular carcinoma
por: Ju, Gaoda, et al.
Publicado: (2021)

Gallic Acid Suppressed Tumorigenesis by an LncRNA MALAT1-Wnt/β-Catenin Axis in Hepatocellular Carcinoma
por: Shi, Chuan-jian, et al.
Publicado: (2021)

Usp5 functions as an oncogene for stimulating tumorigenesis in hepatocellular carcinoma
por: Liu, Yi, et al.
Publicado: (2017)

The relationship between metallothionein-1F (MT1F) gene and hepatocellular carcinoma.
por: Lu, Dong-Dong, et al.
Publicado: (2003)

Cepharanthine inhibits hepatocellular carcinoma cell growth and proliferation by regulating amino acid metabolism and suppresses tumorigenesis in vivo
por: Feng, Fan, et al.
Publicado: (2021)

Targeting TPX2 Suppresses the Tumorigenesis of Hepatocellular Carcinoma Cells Resulting in Arrested Mitotic Phase Progression and Increased Genomic Instability
por: Hsu, Chao-Wen, et al.
Publicado: (2017)

Overexpression of WWP1 Promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma
por: Zhang, Xiao-Fei, et al.
Publicado: (2015)

Treatment with an SLC12A1 antagonist inhibits tumorigenesis in a subset of hepatocellular carcinomas
por: Teng, Fei, et al.
Publicado: (2016)

Methylation-regulated miR-124-1 suppresses tumorigenesis in hepatocellular carcinoma by targeting CASC3
por: Xu, Ling, et al.
Publicado: (2016)

Metallothionein-1G suppresses pancreatic cancer cell stemness by limiting activin A secretion via NF-κB inhibition
por: Li, Kai, et al.
Publicado: (2021)

Downregulating serine hydroxymethyltransferase 2 (SHMT2) suppresses tumorigenesis in human hepatocellular carcinoma
por: Woo, Chern Chiuh, et al.
Publicado: (2016)

Small nucleolar RNA 113–1 suppresses tumorigenesis in hepatocellular carcinoma
por: Xu, Gang, et al.
Publicado: (2014)

PDZ binding kinase, regulated by FoxM1, enhances malignant phenotype via activation of β-Catenin signaling in hepatocellular carcinoma
por: Yang, Yu-Feng, et al.
Publicado: (2017)

Metallothionein 3 Is a Hypoxia-Upregulated Oncogene Enhancing Cell Invasion and Tumorigenesis in Human Bladder Carcinoma Cells
por: Tsui, Ke-Hung, et al.
Publicado: (2019)

SLFN11 inhibits hepatocellular carcinoma tumorigenesis and metastasis by targeting RPS4X via mTOR pathway
por: Zhou, Chenhao, et al.
Publicado: (2020)

Serum copper, zinc and metallothionein serve as potential biomarkers for hepatocellular carcinoma
por: Tamai, Yasuyuki, et al.
Publicado: (2020)

HBx mediated Increase of SIRT1 Contributes to HBV-related Hepatocellular Carcinoma Tumorigenesis
por: Wang, Qing, et al.
Publicado: (2020)

ZNF479 downregulates metallothionein-1 expression by regulating ASH2L and DNMT1 in hepatocellular carcinoma
por: Wu, Yi-Ju, et al.
Publicado: (2019)

Autophagy Suppresses Tumorigenesis of Hepatitis B Virus-Associated Hepatocellular Carcinoma Through Degradation of MicroRNA-224
por: Lan, Sheng-Hui, et al.
Publicado: (2014)

Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenib
por: Houessinon, Aline, et al.
Publicado: (2016)

Integrative Analysis of Metallothioneins Identifies MT1H as Candidate Prognostic Biomarker in Hepatocellular Carcinoma
por: Zhang, Feng, et al.
Publicado: (2021)

Osteopontin is Critical for Hyperactive mTOR-Induced Tumorigenesis in Oral Squamous Cell Carcinoma
por: Gan, Ning, et al.
Publicado: (2017)

LncRNA AY promotes hepatocellular carcinoma metastasis by stimulating ITGAV transcription
por: Kang, Chun Lan, et al.
Publicado: (2019)

Metallothionein MT1M Suppresses Carcinogenesis of Esophageal Carcinoma Cells through Inhibition of the Epithelial-Mesenchymal Transition and the SOD1/PI3K Axis
por: Li, Dandan, et al.
Publicado: (2021)

Critical role of DEK and its regulation in tumorigenesis and metastasis of hepatocellular carcinoma
por: Yu, Le, et al.
Publicado: (2016)

Inhibition of X-linked inhibitor of apoptosis protein suppresses tumorigenesis and enhances chemosensitivity in anaplastic thyroid carcinoma
por: Liu, Yao, et al.
Publicado: (2017)

MLKL inhibits intestinal tumorigenesis by suppressing STAT3 signaling pathway
por: Zhao, Qun, et al.
Publicado: (2021)

EIF3C-enhanced exosome secretion promotes angiogenesis and tumorigenesis of human hepatocellular carcinoma
por: Lee, Hsin-Yi, et al.
Publicado: (2018)

Accumulation of AGO2 Facilitates Tumorigenesis of Human Hepatocellular Carcinoma
por: Yang, Yang, et al.
Publicado: (2020)

Hepatocellular Carcinoma: Tumorigenesis and Prediction Markers
por: Braicu, Cornelia, et al.
Publicado: (2009)

Identification of Prognostic Biomarkers for Suppressing Tumorigenesis and Metastasis of Hepatocellular Carcinoma through Transcriptome Analysis
por: Mishra, Divya, et al.
Publicado: (2023)

Caspase-3 expression in tumorigenesis and prognosis of buccal mucosa squamous cell carcinoma
por: Huang, Jer-Shyung, et al.
Publicado: (2017)

Trace Elements Status and Metallothioneins DNA Methylation Influence Human Hepatocellular Carcinoma Survival Rate
por: Udali, Silvia, et al.
Publicado: (2021)

In silico and experimental analyses predict the therapeutic value of an EZH2 inhibitor GSK343 against hepatocellular carcinoma through the induction of metallothionein genes
por: Liu, Tsang-Pai, et al.
Publicado: (2016)

TCF12 promotes the tumorigenesis and metastasis of hepatocellular carcinoma via upregulation of CXCR4 expression
por: Yang, Jing, et al.
Publicado: (2019)

Ropivacaine suppresses tumor biological characteristics of human hepatocellular carcinoma via inhibiting IGF-1R/PI3K/AKT/mTOR signaling axis
por: Zhang, Runze, et al.
Publicado: (2021)

miR-125a-5p inhibits tumorigenesis in hepatocellular carcinoma
por: Xu, Xin, et al.
Publicado: (2019)

The human vault RNA enhances tumorigenesis and chemoresistance through the lysosome in hepatocellular carcinoma
por: Ferro, Iolanda, et al.
Publicado: (2021)

RRS1 silencing suppresses colorectal cancer cell proliferation and tumorigenesis by inhibiting G2/M progression and angiogenesis
por: Wu, Xin-Lin, et al.
Publicado: (2017)

Activation of VIPR1 suppresses hepatocellular carcinoma progression by regulating arginine and pyrimidine metabolism
por: Fu, Yaojie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ggiumkm8rn1lts0ph3n6ib6o15